Oslo Cancer Cluster Incubator

We wish everyone a happy and sunny holiday! The Incubator is still open and running all summer 😎

Are you curious about the brand new cancer clinic that has opened next door to Oslo Cancer Cluster Innovation Park? Our building is connected to both the clinic building and the Cancer Research Institute by a bridge, showing the short distance between research and patient treatment, as well as, the close collaboration between industry and academia. See pictures and read an article (in Norwegian) about the new Radium Hospital and its proton centre below.

What if we could reduce the side effects of radiation therapy? Kongsberg Beam Technology, a company in OCC Incubator, is developing a technology that aims to make proton therapy more precise. Read about it (in Norwegian): https://lnkd.in/drHPkYGG

“Hardly any modern antibiotics on the market work against MBL-producing bacteria and we now have a technology at hand that can become a game-changer.” Bjørn Klem, CEO of AdjuTec Pharma AS, is ready to take the company's enzyme inhibitor into a First-In-Human clinical trial after the summer. In the first article of our new series The Start-up Spotlight, we interviewed Bjørn to learn more about the health challenge of antimicrobial resistance and the commercial opportunities of the new product his company is developing. This series is produced in collaboration between the Norwegian health clusters Oslo Cancer Cluster, Norway Health Tech, Norwegian Smart Care Cluster, The Life Science Cluster and Biotech North, and funded by Viken fylkeskommune. https://lnkd.in/dq8G3ciG

Hvordan kan helsedata brukes sammen med nye modeller for godkjenning av legemidler, for raskere innføring? Les hva vårt Incubator-selskap NordicRWE skriver sammen med IQVIA i et debattinnlegg i Dagens Medisin. https://lnkd.in/dd8f-A4Z Steinar Thoresen Christian Jonasson Richard Bergstrom Mia Louise Kråkstad

DoMore Diagnostics teknologi skal undersøkes i en pasientkohort på opptil 2500 pasienter etter å ha inngått et samarbeid med Universitair Medisch Centrum Utrecht. – Dette kan bli veldig stort, sier administrerende direktør Torbjørn Furuseth til MedWatch.

DoMore Diagnostics has been awarded the prestigious title of "AI Startup of the Year" by NORA – The Norwegian Artificial Intelligence Research Consortium for its pioneering use of artificial intelligence to personalize cancer treatment.

The Section for Cellular Therapy’s Translational Research Unit in Norway has recently published two groundbreaking studies demonstrating the potential of cell-based therapies in the fight against cancer. They are publishing a third article on a new treatment for Acute myeloid leukaemia (AML).  Sébastien Wälchli Else Marit Inderberg More on the groups recent studies here(Norwegian): https://lnkd.in/dTYJtD5J Read the scientific article here: https://lnkd.in/ddKp2xsN

A description of our latest research and future activities (in Norwegian) on the Oslo University Hospital blog. https://lnkd.in/gnQX_84A

Registration for IHI Call Days is now open! This is your opportunity to get information, network and find partners to apply for funding via the Innovative Health Initiative. Please take special note of the last session: Session on the topic: Patient-centred clinical-study endpoints derived using digital health technologies Friday 21 June | 14:30-15:30 Registration is free: https://lnkd.in/djAnsTAd